An illustrative summary of receptor-mediated mechanisms involved in the therapeutic regulation of type 2 diabetes

This publication has 98 references indexed in Scilit:

• Recent advances in the treatment of type 2 diabetes mellitus using new drug therapies
  The Kaohsiung Journal of Medical Sciences, 2024
• Gα_i‐coupled GPR41 activation increases Ca²⁺ influx in C2C12 cells and shows a therapeutic effect in diabetic animals
  Obesity, 2023
• Signaling pathways and intervention for therapy of type 2 diabetes mellitus
  Medcomm, 2023
• Non-peptidyl small molecule, adenosine, 5′-Se-methyl-5′-seleno-, 2′,3′-diacetate, activates insulin receptor and attenuates hyperglycemia in type 2 diabetic Leprdb/db mice
  Cellular and Molecular Life Sciences, 2019
• Gingerenone A Sensitizes the Insulin Receptor and Increases Glucose Uptake by Inhibiting the Activity of p70 S6 Kinase
  Molecular Nutrition & Food Research, 2018
• Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges
  Medicinal Research Reviews, 2017
• 8‐pCPT‐2′‐O‐Me‐cAMP‐AM: An Improved Epac‐Selective cAMP Analogue
  ChemBioChem, 2008
• Regulation of insulin receptor function
  Cellular and Molecular Life Sciences, 2007
• Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine
  Cell and tissue research, 2006
• Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms
  Diabetes/Metabolism Research and Reviews, 2001